Next-generation sequencing improves diagnostic accuracy of imaging and carcinoembryonic antigen alone for pancreatic cystic neoplasms
Open Access
- 14 November 2024
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 24 (8) , 1322-1331
Abstract
No abstract availableKeywords
Funding Information
- Finnish Medical Association
This publication has 42 references indexed in Scilit:
- Evaluation and diagnostic value of next‐generation sequencing analysis of residual liquid‐based cytology specimens of pancreatic massesCancer Cytopathology, 2021
- KRAS/GNAS‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreasGenes, Chromosomes and Cancer, 2021
- Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinomaGastrointestinal Endoscopy, 2021
- Molecular epidemiology and diagnostics of KRAS mutations in human cancerCancer and Metastasis Reviews, 2020
- Interobserver agreement among expert pathologists on through-the-needle microforceps biopsy samples for evaluation of pancreatic cystic lesionsGastrointestinal Endoscopy, 2019
- Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreasSurgery Today, 2019
- Risk of malignancy in resected pancreatic mucinous cystic neoplasmsBritish Journal of Surgery, 2018
- Pancreatic Cyst DiseaseJAMA, 2016
- Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realitiesEuropean Journal of Cancer, 2016
- Role of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences, 2010